Intratio
Loading...
Skip to main content
Model output · Signal date 2026-11-06

Milestone Scientific Inc. (MLSS) Stock Forecast Nov. 6, 2026

Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE

Share
X LinkedIn Reddit WhatsApp Telegram
Embed badge
Unlock full AI forecasts
Rating · 90D Unlock rating and forecasts
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage of 5150 stocks scored
Rank correlation · 90D -8.0% Spearman, 357 dates
Market Cap $27M small-cap · #18 of 26 peers
Summary

Milestone Scientific Inc. (MLSS) stock forecast summary

Our AI scores Milestone Scientific Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.

Milestone Scientific Inc. is a small-cap company with a market capitalization of $27M. It ranks number 18 by market capitalization among the 26 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast.

For MLSS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -8.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 15.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, MLSS included.

Price

MLSS price chart and AI forecast

MLSS
Cross-section · 2026-11-06

How MLSS ranks among 5150 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-06-30

Milestone Scientific Inc. (MLSS) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.

Valuation & Market

MetricMLSSIndustry medianRank
Market Cap $27M $78M 18/26
P/B Ratio 7.65x 2.48x 6/20
EPS $-0.08 – –
Book Value/Share $0.04 – –
Revenue/Share $0.13 – –
FCF/Share $-0.01 – –

Profitability & Margins

MetricMLSSIndustry medianRank
ROE -119.4% -25.0% 13/19
ROA -49.6% -12.9% 16/19
ROIC -154.4% -4.9% 21/21
Gross Margin 70.9% 47.3% 2/19
Operating Margin -52.4% -8.2% 14/20
Net Margin -35.6% -14.9% 14/18
EBT Margin -52.7% -13.2% 14/20

Financial Health

MetricMLSSIndustry medianRank
Current Ratio 1.85x 2.55x 19/24
Quick Ratio 1.14x 1.66x 17/21
D/E Ratio 1.41x 0.77x 7/23
Financial Leverage 2.41x 1.77x 7/23
Interest Coverage -310.1x -4.4x 18/20
Working Capital $4M $71M 20/24

Cash Flow

MetricMLSSIndustry medianRank
Operating Cash Flow -$640K -$680K 11/24
Free Cash Flow -$660K $4M 9/15
Capital Spending -$20K -$2M 2/15
FCF/Sales -5.7% 3.0% 11/15
CapEx/Sales 0.2% 1.7% 13/15

Operational Efficiency

MetricMLSSIndustry medianRank
Asset Turnover 1.40x 0.64x 2/17
Inventory Turnover 1.1x 2.1x 16/21
Fixed Assets Turnover 579.0x 5.1x 1/18
Days Inventory 332 days 177 days 6/21

Income Statement

MetricMLSSIndustry medianRank
Total Revenue $12M $150M 14/18
Operating Income -$6M -$7M 12/24
Net Income -$4M -$7M 9/20
R&D Expense $460K $20M 20/21
SG&A Expense $14M $172M 18/21
Cost of Goods Sold $3M $73M 15/21

Dividend & Shareholder Information

MetricMLSSIndustry medianRank
Shares Outstanding 89M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$8M97.3% of assets
Cash & Short-term Investments$2M24.8% of assets
Inventory$3M37.0% of assets
Total Liabilities$5M58.4% of assets
Quarterly Financial Reports

MLSS quarterly financials and insider trading

Industry Peers · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Milestone Scientific Inc. (MLSS) industry peers

Companies classified under the same SEC industry code as Milestone Scientific Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 26 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
MLSS Milestone Scientific Inc. $27M – 7.7x
ISRG Intuitive Surgical Inc $156.96B 54.9x 9.8x
STE Steris Plc $24.60B 31.0x 3.4x
ZBH Zimmer Biomet Holdings, Inc. $20.38B 21.9x 1.6x
SNN Smith & Nephew Plc $13.67B 17.9x –
ALGN Align Technology Inc $11.79B 24.2x 2.7x
MSA Msa Safety Inc $6.56B 21.8x 4.6x
ESTA Establishment Labs Holdings Inc. $1.92B – 88.9x
ENOV Enovis Corp $1.57B – 1.1x
CDRE Cadre Holdings, Inc. $1.40B 29.1x 3.8x
AVR Anteris Technologies Global Corp. $555M – 2.2x
SMTI Sanara Medtech Inc. $290M – 36.5x
INGN Inogen Inc $160M – 0.9x
LAKE Lakeland Industries Inc $89M – 0.7x
NTRB Nutriband Inc. $68M – 12.7x
APT Alpha Pro Tech Ltd $56M 14.1x 0.9x
COCH Envoy Medical, Inc. $55M – –
MYO Myomo, Inc. $48M – 8.2x
LFWD Lifeward Ltd. $16M – 1.3x
CUPR Cuprina Holdings (Cayman) Ltd $12M – –
UEEC United Health Products, Inc. $10M 3.8x –
RGNT Regentis Biomaterials Ltd. $8M – 1.7x
CLGN Collplant Biotechnologies Ltd $7M – 1.2x
BBLG Bone Biologics Corp $1M – 0.2x
FEED Envue Medical, Inc. $240K – –
RBOT Vicarious Surgical Inc. $10K – –

Where MLSS sits on the market map

Industrial Applications and Services · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Explore the map →
News

Milestone Scientific Inc. (MLSS) stock news

More news available

Sign up free to read all 11 news articles and stay updated on market developments.

Sign Up Free to Read More
FAQ

Milestone Scientific Inc. (MLSS) stock forecast FAQ

What is the Milestone Scientific Inc. (MLSS) stock forecast?

Our AI scores Milestone Scientific Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.

How accurate are Milestone Scientific Inc. stock predictions?

For MLSS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -8.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 15.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Milestone Scientific Inc. forecasts updated?

Milestone Scientific Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.

Which companies are Milestone Scientific Inc.'s industry peers?

26 issuers in our coverage, MLSS included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Smith & Nephew Plc (SNN), Align Technology Inc (ALGN), Msa Safety Inc (MSA).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.